Dicyandiamide: Global Strategic Business Report

Global Dicyandiamide Market to Reach $566.9 Million by 2030

The global market for Dicyandiamide estimated at US$346.4 Million in the year 2022, is projected to reach a revised size of US$566.9 Million by 2030, growing at a CAGR of 6.3% over the analysis period 2022-2030. Pharmaceutical, one of the segments analyzed in the report, is projected to record 7.6% CAGR and reach US$266.8 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Electronic segment is readjusted to a revised 5.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $93.2 Million, While China is Forecast to Grow at 10.8% CAGR

The Dicyandiamide market in the U.S. is estimated at US$93.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$138.9 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 6.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Select Competitors (Total 46 Featured) -

• AlzChem Group AG
• Ningxia Blue-White-Black Activated Carbon Co. Ltd.
• Ningxia Darong Industry Group Co., Ltd.
• Ningxia Jiafeng Chemicals Co., Ltd.
• Ningxia Sunnyfield Chemical Co. Ltd.
• Shizuishan Pengsheng Chemical Co., Ltd.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and the publisher's Research Platform
• Complimentary updates for one year